Vitamin D3 influence the Th1/Th2 ratio in C57BL/6 induced model of experimental autoimmune encephalomyelitis

Document Type: Original Article

Authors

1 Department of Anatomy, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran Department of Medical Basic Sciences, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

2 Department of Anatomy, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran .epartment of Medical Basic Sciences, Faculty of Allied Medicine, Tehran, Iran.Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran

3 Department of Anatomy, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran .Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran

4 Department of Medical Basic Sciences, Faculty of Allied Medicine, Tehran, Iran

5 Department of Neuroscience, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Objective(s): Multiple Sclerosis (MS) is known as a progressive inflammatory CNS disease. Cytokines belong to Th1 or Th2 family and inflammatory cells, play significant role in pathophysiology of MS. Thus, any treatment supposed to influence the relation between Th1 to Th2 cytokines expression. Although vitamin D has been prescribed as a therapeutic supplement of MS for a long time, it is not clear how much it may affect the Th1/Th2 ratio. To answer this question the present research was designed. 
Materials and Methods: Thirty C57BL/6 adult female mice were used. The animals were randomly divided into trial and control groups. Experimental Autoimmune Encephalomyelitis (EAE) modeling for MS and clinical scoring as cited by others was used. Based on scoring and step of the disease vitamin D3 prescription (5 mg/kg) started and continued for three weeks.
Results: By using ELISA and RT-PCR the brain level of TNF-α, IL-10, IL-4 and IL-12 determined. Significant decrease of clinical symptoms in trial group which received vitamin D was seen comparing to control animals (P<0.05). The level of TNF-α but not IL-10 significantly decreased following vitamin D3 administration. By comparing the level of Th1 and Th2 Interleukins and counting the ratio of them we found that in treated animals the ratio was significantly less than non-treated (P =0.01).
Conclusion: According to the results, vitamin D3 may be able to suppress the inflammatory ways that lead to progression of MS. Whether this ability is clinically valuable in human subjects is not clear and needs more clinical research.

Keywords


1. Sloka S, Silva C, Wang J, Yong V W. Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism. J Neuroinflammation 2011; 8:56.

2. Eikelenboom MJ, Killestein J, Kragt JJ, Uitdehaag BM, Polman CH. Gender differences in multiple sclerosis:  cytokines and vitamin D. J Neurol Sci 2009; 286:40-42.

3. Kidd P. Th1/Th2 balance:  the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003; 8:223-246.

4. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005; 23:683-747.

5. Begolka WS, Vanderlugt CL, Rahbe SM, Miller SD. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J Immunol 1998; 161:4437-4446.

6. Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4- deficient and transgenic mice. J Immunol 1998; 161:3299-3306.

7. Issazadeh S, Ljungdahl A, Höjeberg B, Mustafa M, Olsson T. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis:  dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta. J Neuroimmunol 1995; 61:205-212.

8. Kuroda Y, Shimamoto Y.Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats. J Neuroimmunol 1991; 34:159-164.

9. Liu J, Marino MW, Wong G, Grail D, Dunn A, Bettadapura J, et al. TNF is a potent anti-inflammatory cytokine in autoimmunemediated demyelination. Nat Med 1998; 4:78-83.

10. Wiseman H. Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action. FEBS Lett  1993; 327:285-288.

1[1]. Freedman DM, Dosemeci M, Alavanja MC. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation:  a case-control study based on death certificates. Occup Environ Med 2000; 57:418-421.

12. Van der Mei IA, Ponsonby AL, Blizzard L, Dwyer T. Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 2001; 20:168-174.

13. Esparza ML, Sasaki S, Kesteloot H. Nutrition, latitude, and multiple sclerosis mortality:  an ecologic study. Am J Epidemiol 1995; 142:733-737.

14. Goldberg P.  Multiple sclerosis:  vitamin D and calcium as environmental determinants of prevalence. Sunlight, dietary factors and epidemiology. Int J Environ Stud 1974; 6:19-27.

15. Smolders J, Damoiseaux J, Menheere P, Hupperts R. Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol 2008; 194:7-17.

16. Sioka C, Kyritsis AP, Fotopoulos A. Multiple sclerosis, osteoporosis, and vitamin D. J NeurolSci 2009; 287:1-6.

17. Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 1996; 93:7861-7864.

18. Rausch-Fan X, Leutmezer F, Willheim M, Spittler A, Bohle B, Ebner C, et al. Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific th cell clones by 1alpha,25-dihydroxyvitamin D3. Int Arch Allergy Immunol 2002; 128:33-41.

19. Lafaille JJ. The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev 1998; 9:139-151.

20. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunology Today 1996; 17:138-146.

21. Begolka WS, Miller SD. Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis. Res Immunol 1998; 149:771-781.

22. Brosnan CF, Cannella B, Battistini L, Raine CS. Cytokine localization in multiple sclerosis lesions:  correlation with adhesion molecule expression and reactive nitrogen species. Neurology 1995; 45:S16-S21.

23. Akassoglou K, Bauer J, Kassiotis G, Pasparakis M, Lassmann H, Kollias G, et al. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice:  models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol 1998; 153:801-813.

24. Strle K, Zhou JH, Shen WH, Broussard SR, Johnson RW, Freund GG, et al. Interleukin -10 in the brain. Crit Rev Immunol 2001; 21:427-449.

25. Cammer W. Protection of cultured oligodendro-cytes against tumor necrosis factor-alpha by the antioxidants coenzyme Q (10) and N-acetyl cysteine. Brain Res Bull. 2002; 58:587-592.

26. Garcion E, Sindji L, Nataf S, Brachet P, Darcy F, Montero-Menei CN. Treatment of experimental autoimmune encephalomyelitis in rat by 1, 25-dihydroxyvitamin D3 leads to early effects within the central nervous system. Acta Neuropathol 2003; 105:438-448.

27. Cantorna M. Vitamin D and its role in immunology:  multiple sclerosis and inflammatory bowel disease. ProgBiophysMolBiol 2006; 92:60-64.

28. Van Amerongen BM, Dijkstra CD, Lips P, Polman CH. Multiple sclerosis and vitamin D:  an update. Eur J Clin Nutr  2004; 58:1095-1109.

29. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, et al. Extrarenal expression of 25-hydroxy vitamin D(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001; 86:888–894.

30. Eyles D, Brown J, Mackay-Sim A, McGrath J,Feron F. Vitamin D3 and brain development. Neuroscience 2003; 118:641-653.

31. Garcion E, Nataf S, Berod A, Darcy F, Brachet P. 1,25- Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Mol Brain Res 1997; 45:255-267.

32. Nashold FE, Hoag KA, Goverman J, Hayes CE. Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis. J Neuroimmunol 2001; 119:16-29.

33. Muthian G, Raikwar HP, Rajasingh J, Bright JJ. 1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgama axis leading to Th1 response in experimental allergic encephalomyelitis. J Neurosci Res 2006; 83:1299-1309.

34. Nashold F, Miller D, Hayes C.1,25-Dihydroxyvitamin D treatment decreases macrophage  accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 2000; 103:171-179.

35. Mosayebi G, Ghazavi A, Payani MA. The effect of vitamin D3 on the inhibition of experimental autoimmune encephalomyelitis in C57BL/6 mice. RJMS 2006; 13:189-196

36. Ghazavi A, Mosayebi G. The mechanism of sesame oil in ameliorating experimental autoimmune encephalomyelitis in C57BL/6 mice. Phytother Res 2012; 26: 34-38.

37. Wergeland S, Torkildsen O, Myhr K-M, Aksnes L, Mork SJ. Dietary vitamin D3 supplements reduce demyelination in the cuprizone model. PLoS One 2011; 6:e26262.